FdaApplication
ANDA 216204
Identifiers
- fda_app_no: ANDA216204
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2022-05-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IBUPROFEN AND DIPHENHYDRAMINE CITRATE | DIPHENHYDRAMINE CITRATE; IBUPROFEN | 38MG;200MG | TABLET;ORAL |
1 product